Abbott Launches FreeStyle LibreLink App in China, Ushering in a New Era of Mobile-Connected Glucose Monitoring

January 18, 2021, a globally leading healthcare companyAbbottAnnouncement,DiabetesAnother Frontier Technology in Glucose Monitoring—FreeStyle LibreLink App Officially Launched in China. Its iOS Version Was Released on January 15, and the Android Version Will Be Available on the 26th. This Is a Mobile Application Innovatively Developed Based on the FreeStyle Libre Flash Glucose Monitoring System.app, making "mobile phone glucose monitoring" an easy, flexible, and efficientDiabetesmanagement model has become a reality. The launch of FreeStyle Libre marks the beginning of Abbott's digital mobile connectivity era.DiabetesA New Management Model, forDiabetesProvides another innovative solution for effective patient disease management.

China is a country with a large diabetic population, and the situation for diabetes prevention and control is very severe.1Glucose monitoring has always been the most critical component of comprehensive diabetes management. However, many patients neglect regular glucose testing due to inconveniences in operation and other factors, leading to abnormal blood glucose fluctuations, increased risk of complications, and significant adverse impacts on physical health and quality of life. With the rapid advancement of scientific concepts in comprehensive diabetes management in recent years, mobile internet-based healthcare has gradually emerged as a new approach to improving diabetes management. Abbott FreeStyle Libreapp, enabling diabetic patients to scientifically manage their disease based on mobile internet technology, and freely enjoy a healthy and high-quality life.

The FreeStyle Libre app functions similarly to the FreeStyle Libre reader. Patients can scan the FreeStyle Libre sensor with their smartphone to instantly monitor glucose levels and obtain glucose trend data from the past 8 hours. As carrying a dedicated reader is no longer required, the overall operation becomes more discreet and convenient. Compared to the reader, the FreeStyle Libre appappThe charts feature richer content, and the mobile interface is larger, clearer, and more user-friendly, making relevant data and information immediately accessible at a glance. Additionally, it includes a glycated hemoglobin (HbA1c) prediction function [requires available sensor glucose data from the past 90 days to estimate HbA1c], eliminating the need for patients to import data to a PC.Software, you can conveniently view your blood glucose control levels for the past 90 days.

When using the FreeStyle Libre app, patients can also log notes on diet, insulin injections, exercise, and other relevant factors within the app, enabling more proactive, precise, and systematic disease management; they can also share this information with a single tap.appCharts for family members and healthcare providers to help them develop more personalized and scientific management plans for the patient's health.

Dr. Xiang Yu, General Manager of Abbott’s Diabetes Care business for Greater China and Emerging Asia, stated, “As a global leader in healthcare, Abbott remains dedicated to technological innovation in the field of diabetes. With this launch of FreeStyle Libre...”app“By adding digital management tools, we have made the entire FreeStyle family product portfolio more complete, providing more choices for patients in China. In addition to continuously launching innovative solutions for disease management, Abbott is also actively collaborating with industry partners to further enhance product accessibility, ensuring that cutting-edge technologies benefit more people with diabetes. In the future, we will continue to deepen our presence in the Chinese market, accelerate the introduction of new products into China, promote diversified collaboration models, and further improve the diabetes management ecosystem, helping an increasing number of people with diabetes effectively manage their condition and enjoy a healthy life.”

For over 130 years, Abbott has been committed to providing convenient, comfortable, and efficient glucose monitoring products and services for people with diabetes, ensuring that the diagnosis and treatment of diabetes can operate safely and effectively based on precise monitoring. FreeStyle LibreappThe market launch has enabled an increasing number of Chinese patients with diabetes to enjoy healthier and more freedom-filled lives. In the future, Abbott will continue to address the practical needs of diabetes management in China, consistently introducing safe, effective, and innovative customized disease management solutions, while actively pursuing industry collaborations to help more patients scientifically manage their condition and fully embrace the vibrancy of life.(Bioon.com)